Pneumocystis pneumonia in patient with lung adenocarcinoma: early side effects from pembrolizumab

Immune check point inhibitor has made far-reaching changes in the management of lung adenocarcinoma improving drastically the prognosis. We present a case of a 50 years old women beneficiary of pembrolizumab who has suffered an acute pneumonitis diagnosed with CT imaging the days following the initi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiba, Zahi, Abdelmoughit, Hosni, Zaynab, Iraqi Houssaini, Hounaida, Jerguigue, Rachida, Latib, Youssef, Omor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411188/
https://www.ncbi.nlm.nih.gov/pubmed/36032207
http://dx.doi.org/10.1016/j.radcr.2022.07.083
_version_ 1784775262805688320
author Hiba, Zahi
Abdelmoughit, Hosni
Zaynab, Iraqi Houssaini
Hounaida, Jerguigue
Rachida, Latib
Youssef, Omor
author_facet Hiba, Zahi
Abdelmoughit, Hosni
Zaynab, Iraqi Houssaini
Hounaida, Jerguigue
Rachida, Latib
Youssef, Omor
author_sort Hiba, Zahi
collection PubMed
description Immune check point inhibitor has made far-reaching changes in the management of lung adenocarcinoma improving drastically the prognosis. We present a case of a 50 years old women beneficiary of pembrolizumab who has suffered an acute pneumonitis diagnosed with CT imaging the days following the initiation of the drug. The occurrence of immune-related events such as pneumonitis complicates the use of immunotherapy and requires a well verse radiologist in the matter to diagnosis and helps prevent further aggravation.
format Online
Article
Text
id pubmed-9411188
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94111882022-08-27 Pneumocystis pneumonia in patient with lung adenocarcinoma: early side effects from pembrolizumab Hiba, Zahi Abdelmoughit, Hosni Zaynab, Iraqi Houssaini Hounaida, Jerguigue Rachida, Latib Youssef, Omor Radiol Case Rep Case Report Immune check point inhibitor has made far-reaching changes in the management of lung adenocarcinoma improving drastically the prognosis. We present a case of a 50 years old women beneficiary of pembrolizumab who has suffered an acute pneumonitis diagnosed with CT imaging the days following the initiation of the drug. The occurrence of immune-related events such as pneumonitis complicates the use of immunotherapy and requires a well verse radiologist in the matter to diagnosis and helps prevent further aggravation. Elsevier 2022-08-17 /pmc/articles/PMC9411188/ /pubmed/36032207 http://dx.doi.org/10.1016/j.radcr.2022.07.083 Text en © 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Hiba, Zahi
Abdelmoughit, Hosni
Zaynab, Iraqi Houssaini
Hounaida, Jerguigue
Rachida, Latib
Youssef, Omor
Pneumocystis pneumonia in patient with lung adenocarcinoma: early side effects from pembrolizumab
title Pneumocystis pneumonia in patient with lung adenocarcinoma: early side effects from pembrolizumab
title_full Pneumocystis pneumonia in patient with lung adenocarcinoma: early side effects from pembrolizumab
title_fullStr Pneumocystis pneumonia in patient with lung adenocarcinoma: early side effects from pembrolizumab
title_full_unstemmed Pneumocystis pneumonia in patient with lung adenocarcinoma: early side effects from pembrolizumab
title_short Pneumocystis pneumonia in patient with lung adenocarcinoma: early side effects from pembrolizumab
title_sort pneumocystis pneumonia in patient with lung adenocarcinoma: early side effects from pembrolizumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411188/
https://www.ncbi.nlm.nih.gov/pubmed/36032207
http://dx.doi.org/10.1016/j.radcr.2022.07.083
work_keys_str_mv AT hibazahi pneumocystispneumoniainpatientwithlungadenocarcinomaearlysideeffectsfrompembrolizumab
AT abdelmoughithosni pneumocystispneumoniainpatientwithlungadenocarcinomaearlysideeffectsfrompembrolizumab
AT zaynabiraqihoussaini pneumocystispneumoniainpatientwithlungadenocarcinomaearlysideeffectsfrompembrolizumab
AT hounaidajerguigue pneumocystispneumoniainpatientwithlungadenocarcinomaearlysideeffectsfrompembrolizumab
AT rachidalatib pneumocystispneumoniainpatientwithlungadenocarcinomaearlysideeffectsfrompembrolizumab
AT youssefomor pneumocystispneumoniainpatientwithlungadenocarcinomaearlysideeffectsfrompembrolizumab

Ejemplares similares